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ABSTRACT We prepared a monoclonal antibody to microtubule-associated protein 1 (MAP
1), one of the two major high molecular weight MAP found in microtubules isolated from
brain tissue . We found that MAP 1 can be resolved by SDS PAGE into three electrophoretic
bands, which we have designated MAP ]A, MAP 113, and MAP 1 C in order of increasing
electrophoretic mobility. Our antibody recognized exclusively MAP 1A, the most abundant
and largest MAP 1 polypeptide. To determine the distribution of MAP 1A in nervous system
tissues and cells, we examined tissue sections from rat brain and spinal cord, as well as primary
cultures of newborn rat brain by immunofluorescence microscopy. Anti-MAP 1 A stained white
matter and gray matter regions, while a polyclonal anti-MAP 2 antibody previously prepared
in this laboratory stained only gray matter. This confirmed our earlier biochemical results,
which indicated that MAP 1 is more uniformly distributed in brain tissue than MAP 2 (Vallee,
R . B., 1982, /. Cell Biol., 92 :435-442). To determine the identity of cells and cellular processes
immunoreactive with anti-MAP 1A, we examined a variety of brain and spinal cord regions.
Fibrous staining of white matter by anti-MAP 1A was generally observed. This was due in part
to immunoreactivity of axons, as judged by examination of axonal fiber tracts in the cerebral
cortex and of large myelinated axons in the spinal cord and in spinal nerve roots . Cells with
the morphology of oligodendrocytes were brightly labeled in white matter. Intense staining of
Purkinje cell dendrites in the cerebellar cortex and of the apical dendrites of pyramidal cells
in the cerebral cortex was observed. By double-labeling with antibodies to MAP 1A and MAP
2, the presence of both MAP in identical dendrites and neuronal perikarya was found. In
primary brain cell cultures anti-MAP 2 stained predominantly cells of neuronal morphology.
In contrast, anti-MAP 1A stained nearly all cells. Included among these were neurons,
oligodendrocytes and astrocytes as determined by double-labeling with anti-MAP 1A in
combination with antibody to MAP 2, myelin basic protein or glial fibrillary acidic protein,
respectively. These results indicate that in contrast to MAP 2, which is specifically enriched in
dendrites and perikarya of neurons, MAP lA is widely distributed in the nervous sytem .
Microtubules purified from a variety of sources have been
shown to consist of both tubulin, the principal structural
protein, and a diverse group of microtubule-associated pro-
teins, or MAP (5, 6, 27, 34, 45, 46). The MAP have been
implicated in the regulation ofmicrotubule assembly (26, 46),
and. in mediating the interaction of microtubules with other
structural elements ofthe cytoplasm (1, 3, 12, 13, 15, 22, 32,
33, 35).
In brain, the most prominent MAP are high molecular
weight proteins. These proteins have been divided into two
classes, MAP 1 and MAP 2, on the basis oftheir electropho-
retic mobility (34). MAP 2 (M, 270,000) remains soluble
when microtubules are exposed to elevated temperature, a
property that allows this protein to be readily separated from
MAP 1 (14, 17). MAP 2 purified in this way is seen as a fine
filamentous arm on the surface ofmicrotubules and promotes
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severe conditions contains low molecular weight subunits of
Mr 70,000, 54,000, and 39,000 (42). The latter two of these
proteins represent the regulatory and catalytic subunits of a
type II cAMP dependent protein kinase, which is associated
with the MAP 2 arm (36, 42) and which extensively phospho-
rylates MAP 2 itself(34, 37, 39). MAP 2 is unusually sensitive
to digestion by chymotrypsin and trypsin, which results in the
rapid release of the arm portion of the protein from the
microtubule (39, 41). The protein binds to actin in vitro (13,
32) and to intermediate filaments in cultured cells (3).
Like MAP 2, MAP 1 (M, -350,000) appears as a filamen-
tous arm of similar dimension on the microtubule surface
(43), and promotes microtubule assembly (20, 43). MAP 1 is
as sensitive to proteases as MAP 2 (41) and much of the mass
of MAP 1, as well as MAP 2, is rapidly released from the
microtubules during protease treatment. MAP 1 is as stable
as MAP 2 to some denaturants (43), but is insoluble at
elevated temperatures (14, 17). Like MAP 2, MAP 1 contains
low molecular weight subunits, but these are distinct in mo-
lecular weight (Mr 28,000 and 30,000) and stoichiometryfrom
those associated with MAP 2 (43). MAP 1 is only slightly
phosphorylated in vitro compared with MAP 2 (34, 39). In
addition to these distinctions, antibodies, to MAP 2, the
smaller of the two proteins, have not been observed to react
with MAP 1 (3, 16, 29).
Thus, it appears that while MAP 1 and MAP 2 are two
members of a class of structural proteins associated with
microtubules, they have several distinctive features. Presum-
ably, these features indicate that the proteins are functionally
distinct as well. In support ofthis contentionwe have recently
obtained biochemical evidence that MAP 1 and MAP 2 are
differentially distributed in microtubules isolated from calf
cerebral cortex and corpus callosum (40). These two brain
regions contain distinct cellular and subcellular elements.
Neuronal cell bodies, dendrites and axons, as well as glial
cells, are present in cerebral cortex gray matter, while only
axons and glial cells are present in white matter. MAP 2 is
most abundant in microtubules isolated from calf cerebral
cortex, but is greatly diminishedin microtubules isolated from
calf corpus callosum. MAP 1, in contrast to MAP 2, is present
in identical amounts in microtubules from the two brain
regions. Consistent with the nonuniform distribution ofMAP
2 is the observation that antibody prepared against MAP 2
intensely stains neuronal cell bodies and dendrites in rat brain
gray matter, but fails to stain glial cells and axonal processes
appreciably in white matter tracts (8, 24; see Figs. 3 and 8 in
this paper). These observations indicate that MAP 2 has a
relatively restricted cellular and subcellular distribution, con-
sistent with observations on cultured cells(3, 16, 29), radioim-
mune assays oftissue extracts (38), and an immunocytochem-
ical study using an antibody to unfractionated high molecular
weight brain MAP (23). In the latter study immunoreactivity
was not detected in whitematter tracts, suggesting that neither
MAP 1 nor 2 is present in axonal processes or nonneuronal
cellsof central nervous system tissue. This contrasts our own
biochemical work described above (40), which indicates that
MAP 1 is abundant in white matter.
In the present study, we sought to define the cellular and
subcellular distribution of MAP 1 and to compare the distri-
bution of this protein with MAP 2. To this end we have
prepared a monoclonal antibody to MAP 1 . We found that
MAP 1 is a complex of electrophoretic bands that can be
divided into three biochemically distinguishable species. Our
antibody recognizes the most abundant of these species, to
which we now refer as MAP 1A. Consistent with our earlier
biochemical results (40), we find that the immunoreactive
MAP 1 species is widespread in brain and spinal cord com-
paredto MAP 2. In the accompanying paper (4) we survey a
broad variety of cells derived from diverse tissues and show
that MAP IA is commonly found outside of the nervous
system as well.
MATERIALS AND METHODS
Monoclonal Antibody Production:
￿
A BALB/c mouse was in-
jected subcutaneously with MAP 1 on two occasions spaced 6 wk apart. The
immunogen was isolated from microtubules prepared from calfbrain cerebral
cortex by three temperature-dependent assembly cycles (42). The microtubule
proteinswere separated by SDS PAGE on a 9% polyacrylamide slab gel, which
was stained with Coomassie Brilliant Blue R250. A strip ofthe gel containing
the three MAP I bands (see Results) was excised, homogenized in 20 mM
sodium phosphate, pH 7.4/150 mM NaCl, and emulsified by sonication with
an equal volume ofFreund's complete adjuvant. 10 d afterthe second injection,
the mouse was given a final intraperitoneal boost of native MAP 1 prepared
from calf brain white matter (43).
4 d afterthe final injection, immune spleniclymphocytes were collected and
fused (18) with P3-NSI/1-Ag4-l (NS1) mouse myeloma cells in a solution
containing RPMI 1640 (Gibco Laboratories, Grand Island Biological Co.,
Grand Island, NY), 37% polyethylene glycol 1000 (Koch-Life Laboratories,
Ltd.; Colnbrook, Buckinghamshire, England) and 5% DMSO (Sigma Chemical
Co., St. Louis, MO). Cells were plated in 24-well tissue culture dishes(Falcon;
Becton Dickinson Labware, Oxnard, CA), where theyweremaintained in HAT
selective medium for 24 h to 2 wk postfusion. Cells were cloned by limiting
dilution in 96-well dishes (Falcon) in a medium containing RPMI 1640, 20%
fetal calfserum (Hy-Clone; Sterile Systems, Logan, UT) and pen/strip (Gibco
Laboratories). Stable clones were maintained in medium containing 10% fetal
calf serum.
Hybridomas, both uncloned and cloned, were screened for antibody pro-
duction by immunofluorescence microscopy ofprimary brain cell cultures (see
below) using conditioned hybridoma medium. Immunoreactive proteins were
subsequently identified by immunoblot analysis (see below), also using condi-
tioned medium. Antibody isotypes were determined by double immunodiffu-
sion (28) with rabbit antibodies specific for mouse antibody isotypes (Bionetics
Laboratory Products, Kensington, MD).
immunocytochemistry and Immunochemistry: Brain and
spinal cord tissues were obtained from young adult (3-4-mo old) female rats.
The animals were anesthetizedwith Nembutal and perfused transcardially with
2% paraformaldehyde, 1.5% picric acid in 0.15 M phosphate buffer at pH 7.3
before dissection of the tissue. Fixation was continued overnight in the same
solution at room temperature. Vibratome sections (20 Am) were collected in
PBS and processed in suspension for single or double immunofluorescence
microscopy as we have described forcultured brain cells (3), with the following
exceptions: the 10% normal serum(sheeporgoat) stepwasperformedovernight
at 4°C in the presence of 0.25% Triton X-100; all subsequent solutions
contained 0.025% Triton X-100; antibody incubations were at 4°C for 24-48
hr. Stained sections were mounted on gelatin-coated glass slides, coated with a
thin film ofelvanol mounting medium (10) and overlaid with glass coverslips.
Primary cultures of newborn rat brain were prepared and processed for single
or double immunofluorescence microscopy after methanol fixation as we have
described (3).
Antibodies used forthese studies were as follows: First antibodies: anti-MAP
2, IA, monoclonal mouse IgGl, described above; anti-MAP 2, polyclonal
rabbit antibody(3, 8, 24, 36); anti-glial fibrillaryacidic protein, rabbitpolyclonal
antibody supplied by Dr. R. Liem (New York University School of Medicine);
antimyelin basic protein, polyclonal rabbit antibody, supplied by Sheryl L.
Preston and Dr. Arthur McMorris (Wistar Institute). Second antibodies: Fluo-
rescein conjugated IgG fraction of goat anti-rabbit IgG was from Cappel
Laboratories (Cochranville, PA). Rhodamine conjugated IgG fraction of sheep
anti-mouse IgG was prepared in our laboratory by the procedure of Forni (9)
from sheep antiserum to mouse IgG (Cappel Laboratories).
Nitrocellulose replicas of SDS gels were prepared and stained with either
conditioned hybridoma medium or ascites fluid antibody using conditions
designed to obtain efficient transfer of high molecular weight polypeptides (3).
The second antibody was peroxidase-conjugated IgG fraction of sheep anti-
mouse IgG (Cappel Laboratories), which was reacted with 4-chloro-I-naphthol
(Sigma Chemical Co.) to reveal the immunoreactive proteins.
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Electrophoretic and Immunochemical Analysis of
MAP 1
An immunoblot ofunfractionated rat brain proteins stained
with the monoclonal IgGI antibody used throughout this
paper is shown in Fig. 1A . Note the specific staining of a
protein at the position of MAP 1 . MAP 1 was originally
defined as a single electrophoretic component on high percent
polyacrylamide gels (34), but multiple bands have been seen
in the MAP 1 region on low percent gels (11). Fig . 1 B shows
high molecular weight brain MAP obtained from calf white
matter (40) . MAP 1 is more prominent than MAP 2 in these
preparations, and we find that the electrophoretic composi-
tion of the MAP 1 region can be more readily analyzed than
in microtubules purified from whole brain or cerebral cortex .
Five polypeptides were readily distinguished in the MAP 1 /
MAP 2 region of the gel (Fig. 1 B) . The two most rapidly
migrating polypeptides were soluble at elevated temperatures,
and reacted with both polyclonal and monoclonal anti-MAP
2 antibodies prepared in our laboratory (44) . These two
polypeptides are therefore considered to be components of
MAP 2 (14, 17), and we refer to them as MAP 2A and MAP
2B . We refer to the three remaining peptides ofhigher molec-
ular weight as MAP 1A, MAP 1 B, and MAP 1C in order of
increasing electrophoretic mobility. MAP IA was the most
prominent of the three polypeptides in both gray matter (not
shown) and white matter microtubules. The band was broad
and was occasionally observed to split into two distinct bands,
FIGURE 1 Electrophoretic and immunochemical properties of
MAP 1 . (A) A newborn rat brain was dissolved in sample buffer and
an aliquot was subjected to SDS PAGE on a 7% polyacrylamide gel .
Left, Coomassie Brilliant Blue R250; right, nitrocellulose replica
stained with anti-MAP 1A (B) 4% gel of microtubules purified by
the taxol procedure (40) from calf corpus callosum . Left, Coomassie
Blue ; right nitrocellulose replica stained with anti-MAP 1A. The
positions of MAP IA, 1B, 1C, 2A, and 2B are indicated . Note the
specificity of the antibody for MAP IA . (C) 4% gel of microtubules
from calf corpus callosum (see B) treated for 10 min with 0.33 Irgl
ml chymotrypsin . (Lanes in B and C were adjacent in original gel
and nitrocellulose replica .) Among the high molecular weight MAP,
MAP 1C alone was resistant to proteolysis, indicating that this is a
protein species distinct from MAP 1A and MAP 1 B . Left, Coomassie
Blue ; right, nitrocellulose replica stained with anti-MAP 1A .
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which suggests that even this species may be heterogeneous .
MAP 1B was the second most prominent band and it split on
occasion . MAP 1B was more prominent in microtubules
purified from white matter than from gray matter (not
shown). The MAP 1C band was the least prominent of the
three bands. This protein could be readily distinguished from
MAP 1A, MAP 1B, and the MAP 2 bands by exposure of the
microtubules to low levels of chymotrypsin . Under these
conditions (Fig. 1 C), all bands except MAP 1C were readily
destroyed (39, 41).
Immunoblot analysis was performed on brain MAP to
determine the specificity of the monoclonal anti-MAP 1
antibody prepared for this study. It may be seen (Fig . 1B and
C) that the antibody recognized only MAP IA, the major
MAP 1 polypeptide. To indicate the specificity of the anti-
body, we refer to it in this and the following paper (4) as anti-
MAP IA . To determine whether the antibody recognized
ankyrin, a major erythrocyte cytoskeletal protein reported to
be immunologically related toMAP 1 (2), we used anti-MAP
IA to stain immunoblots of sheep erythrocyte ghosts and rat
erythrocytes (not shown). The antibody did not react with the
ankyrin present in either sample .
Localization ofMAP 1A in Axons
and Oligodendrocytes
In a previous biochemical studywe found that MAP 1 and
MAP 2 were present at different relative concentrations in
microtubules purified from calf brain gray and white matter
(40) . MAP 2 was considerably more abundant in gray matter
than in white. When sections of brain tissue were examined
by immunofluorescence microscopy, MAP 2 was observed to
be highly concentrated in the dendritic processes of neurons,
and was undetectable in axonal tracts and glial cells (8, 24),
consistent with the biochemical result. On the other hand, the
ratio of MAP 1 to tubulin was identical in microtubules
isolated from gray and white matter (40), suggesting a more
nearly uniform distribution for this protein than for MAP 2 .
To evaluate the distribution ofMAP 1 in tissues ofthe nervous
system, we stained sections oftissue from rat brain and spinal
cord with our anti-MAP 1A monoclonal antibody .
Fig . 2 a shows a low magnification view of rat corpus
callosum white matter and surrounding gray matter of the
cerebral cortex stained with anti-MAP IA . Immunoreactivity
was almost uniformly distributed across the field . This result
is consistent with our biochemical evidence that MAP 1 is
found at equal concentrations in microtubules isolated from
cerebral gray and white matter (40), and suggests that signifi-
cant levels ofMAP 1A may be found in axons or glial cells,
as well as in dendrites . No staining was observed when un-
conditioned medium was used (Fig. 2b) in place of condi-
tioned hybridoma medium containing monoclonal anti-MAP
IA . We found that major cerebral white matter tracts other
than corpus callosum generally stained brightly with anti-
MAP 1 A, but extremely weakly with anti-MAP 2 . An example
of these staining patterns in the anterior commissure is illus-
trated in Fig. 3 . Here, anti-MAP-IA reactivity (Fig . 3a) was
substantial, and was similar to that observed in the adjacent
gray matter (bed nucleus of stria terminalis) . Anti-MAP 2
(Fig. 3 b), in sharp contrast, hardly stained the anterior com-
missure, although apparent dendrites in the adjacent gray
matter were brightly stained .
The immunoreactivity of white matter with anti-MAP 1AFIGURE 2
￿
Localization of MAP 1A in rat cerebral white matter. (a) Sagittal section of corpus callosum white matter (cc) and
adjacent gray matter of the cortex stained with anti-MAP 1A (conditioned hybridoma culture medium) . A portion of the
hippocampus (H) is visible in the lower right corner . (b) Control section processed for immunofluorescence microscopy and
photographed identically to the section in a, except that unconditioned medium was used in place of conditioned hybridoma
medium containing anti-MAP 1A . Bar, 50Am . x 200 .
FIGURE 3
￿
Comparison of MAP 1A and MAP 2 distributions in rat brain . A sagittal section of rat cerebrum was double-labeled
with monoclonal anti-MAP 1A (a) and rabbit anti-MAP 2 (b) followed by rhodamine sheep anti-mouse IgG plus fluorescein goat
anti-rabbit IgG . Visible in the section are a caudal portion of the anterior commissure (AC in b) plus adjacent gray matter (G in b ;
this region corresponds to the bed nucleus of the stria terminalis) . Bar, 50 Am . x 240.
indicated that MAP 1A might be localized there in axons,
glial cells, or both . Fine processes were generally labeled by
the antibody in white matter regions, which could have re-
flected the presence ofMAP lA in either axonal processes or
glial cell processes . The immunoreactivity of axons in partic-
ular was evident in certain regions. Fig . 4 shows a sagittal
section ofrat cerebrum stained with anti-MAP IA . Numerous
longitudinally cut bundles of axons in the immediate vicinity
of the anterior commissure were observed to be intensely
stained by the antibody. These fiber tracts ran from a ventral-
caudal to a dorsal-rostral position and probably correspond
to the striohypothalamic tract (19). In this region, the axonal
staining was as prominent as the staining of dendrites and
neuronal cell bodies in the surrounding tissue . Fig. 5 shows
large myelinated axons in the dorsal root of a spinal nerve .
Staining was observed in the axoplasm ofthese processes, and
was absent in the myelin sheaths . The outer rim of some
myelin sheaths was lightly stained and this may have repre-
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￿
Localization of MAP 1A in axons . A sagittal section of
the cerebrum was stained with anti-MAP 1A . The region shown is
immediately rostral to the anterior commissure, which lies to the
right of the field . The broad fiber bundles indicated by the stars are
longitudinally cut axons, corresponding to the striohypothalamic
tract, which is coursing through the nucleus accumbens . Bar, 20
Am . x 400 .
sented thin regions of Schwann cell cytoplasm surrounding
the sheath . Similar staining by anti-MAP IA was observed in
ventral roots of spinal nerves (not shown) . Thus, in the
peripheral nervous system MAP lA was judged to be present
in axons of identifiable sensory (dorsal root) and motor (ven-
tral root) neurons .
In the spinal cord staining ofmyelinated processes was also
observed (Figs. 5 and 6) . In addition to axonal staining, anti-
MAP 1A stained a class ofcells that were scattered throughout
white matter. At high magnification (Fig. 6, c and d) it could
be seen that both broad and fine processes belonging to these
cells were stained . These processes appeared to contact the
outer layer of unstained myelin sheaths, and did not seem to
contact axons directly . These histological properties are con-
sistent with the identification of these cells as oligodendro-
cytes . Thus, it seemed that MAP 1A is present in both axons
and oligodendrocytes, and may be especially concentrated in
the latter .
Similarities in Anti-MAP 1A and Anti-MAP
2 Immunoreactivity
While MAP lA was always detectable in white matter, the
intensity of staining varied in different regions, as did the
intensity relative to gray matter. In the cerebellum, for ex-
ample (Fig. 7A), white matter staining was relatively weak
compared to that observed in Purkinje cells . Thus, the overall
staining pattern with anti-MAP 1A gave an impression similar
to that observed with anti-MAP 2 (8), though distinct labeling
of fibers in white matter was definitely detectable with anti-
bodies to MAP 1 A, but not to MAP 2 . The somata and
dendrites of the Purkinje cells were among the most promi-
nently stained structures in the central nervous system (Fig .
7, A and B) . Staining of Purkinje cell axons was also seen
(Fig. 7B) . In favorable sections weaker staining could be
observed in granule cell and Golgi neurons in the granule
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layer, and in basket cells in the molecular layer . Fine immu-
noreactive fibers (Fig. 7A) in the molecular layer may repre-
sent both dendrites and axons emanating from basket cell,
Golgi, and granule cell neurons.Some of these processes were
observed to cross the Purkinje cell body layer from the granule
layer to the molecular layer .The fine caliber ofthese processes
indicates they may be climbing fiber or parallel fiber axons .
Since both MAP lA (Fig. 7) and MAP 2 (8, 24) were
prominent in dendrites and neuronal cell bodies, this raised
the question of whether the two proteins coexist in the same
neuron . To resolve this point we double-labeled sections of
brain and spinal cord with anti-MAP 1A and anti-MAP 2 .
Prominent, coincident labeling of large processes and neu-
ronal perikarya in gray matter by both antibodies was gener-
ally observed. Fig. 8 shows examples of this from the spinal
FIGURE 5
￿
Axonal localization of MAP 1A in spinal nerve . A cross-
section of the dorsal root of a spinal nerve in the cervical region is
shown . (a) Anti-MAP 1A stained axoplasm (solid arrow), but not the
surrounding myelin sheaths. Thin halos of immunoreactivity (open
arrow) were occasionally observed surrounding the sheaths, and
these may represent Schwann cell cytoplasm . The brightly stained
area below the spinal nerve is spinal cord white matter, where both
axons and oligodendrocytes are immunoreactive with anti-MAP lA
(see Fig . 6) . (b) Phase-contrast image of the same field . Axons (solid,
long-stemmed arrow) are visible as phase-lucent cores surrounded
by phase-dense myelin sheaths . Phase-contrast image was printed
darkly to optimize contrast between myelin sheaths and axonal
cytoplasm . Bar, 20 ,m . x 650 .FIGURE 6
￿
Localization of MAP 1A in spinal cord white matter . Cross-sections were cut at the cervical region of the spinal cord .
(a) Low magnification view labeled with anti-MAP 1A, illustrating punctate staining of moderate intensity throughout the field,
and occasional brightly stained cells . (b) Low magnification view of a control section processed for immunofluorescence
microscopy and photographed identically to the section shown in a, except that unconditioned hybridoma medium was used in
place of anti-MAP 1A. (c) High magnification view, illustrating cell bodies (solid arrow) and processes (open arrow) of brightly
labeled cells identified as oligodendrocytes . Less intense patches of fluorescence throughout the field represent primarily axons
cut in approximate cross-sections. (d) High magnification view, in which the cytoplasm of an oligodendrocyte (open arrow) is
observed to encircle a myelinated axon . The lightly stained axoplasm (solid arrow) is separated from the oligodendrocyte
cytoplasm by the unstained myelin sheath . Bars : (b, for a and b) 50 jm and (d, for c and d) 10 um . (a and b) x 230. (c and d) x
1,150 .
FIGURE 7 Localization of MAP
1A in cerebellum . Sagittal sec-
tions are shown at low and high
magnification . (A) Low magnifica-
tion view illustrating the histolog-
ical layers of the cerebellum : m,
molecular layer ; g, granule cell
layer ; wm, white matter; open ar-
row, Purkinje cell body ; closed
arrow, Purkinje cell dendrite . Bar,
20 um . (8) High magnification
view of Purkinje cells. Both den-
drites (solid arrow) and axons
(open arrows) of Purkinje cells
contain MAP 1A . (C) High mag-
nification view of white matter .
Cellular processes, presumably
consisting mostly of axons, were
moderately stained throughout
this region . Bar, 10 um . Magnifi-
cation for B and C was the same .
(A) x 250 . (B and C) x 750 .
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￿
Coexistence ofMAP 1A and MAP 2 in neurons . Tissue sections were double-labeled with monoclonal anti-MAP 1A
and rabbit anti-MAP 2 . Second antibodies were rhodamine sheep anti-mouse IgG and fluorescein goat anti-rabbit IgG . (a) Sagittal
section of cerebral cortex showing distribution ofMAP 1A . Apical dendrites (solid arrow) and perikarya (open arrow) of pyramidal
neurons were prominently labeled . (b) Distribution of MAP 2 in the same section . (c) Cross-section of spinal cord gray matter (in
mid-cervical region) showing presence of MAP 1A in perikarya of large (solid arrow) and small (open arrow) motor neurons, as
well as in numerous processes cut in cross and longitudinal sections . (d) Distribution of MAP 2 in the same section . Bar, 10 um .
x 700 .
cord, where motor neurons and numerous processes were
stained by anti-MAP IA and anti-MAP 2, and from the
cerebral cortex, where perikarya and apical dendrites of py-
ramidal neurons were heavily labeled by both antibodies .
Other readily identifiable dendritic processes, such as those in
the cerebellar cortex, were also stained by both antibodies
(not shown) . Thus, while MAP lA alone was detectable in
axons and glial cells, both MAP IA and MAP 2 appeared to
be abundant in dendrites and neuronal cell bodies .
Immunofluorescent Detection of MAP 1A in
Cultured Brain Cells
To obtain further information on the identity of cells
containing MAP IA, we examined primary cultures of new-
born rat brain . Fig . 9 shows cells double-stained with anti-
MAP 1A (Fig . 9 a) and anti-MAP 2 (Fig . 9 b) . The latter
antibody stained only a limited number of cells in these
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cultures, as reported previously (3, 16, 29) . Most ofthese cells
were of neuronal morphology and contained receptors for
tetanus toxin (3), consistent with the neuronal localization of
MAP 2 found in brain and spinal cord (8, 24) . In contrast to
MAP 2, anti-MAP lA stained most cells in the culture, albeit
with varying intensity . The MAP 2-positive cells of neuronal
morphology were consistently stained by anti-MAP IA, al-
though with only moderate intensity. An additional class of
cells, which were MAP 2-negative and were characterized by
small cell bodies and long processes, also stained with anti-
MAP IA . These cells appeared to contain the highest concen-
trations ofMAP IA found in the cultures.
To determine the identity of these cells, we stained the
cultures with antibodies specific for glial cells . Fig. 10 shows
the result of double immunofluorescence microscopy per-
formed with anti-MAP IA and antimyelin basic protein, a
marker for oligodendrocytes (25) . Anti-MBP (Fig. 10b) in-
tensely stained a fraction of the cells in the culture . TheseFIGURE 9
￿
Distinct cellular expression of MAP 1A and MAP 2 in
primary cultures of newborn rat brain . A coverslip was labeled with
monoclonal anti-MAP 1 A (a) and rabbit anti-MAP 2 (b, followed by
rhodamine sheep anti-mouse IgG and fluorescein goat anti-rabbit
IgG . (c) Phase-contrast image of the same field . Bar, 10 jcm . x 650 .
cells were the same as those most intensely stained with anti-
MAP 1A (Fig. 10 a) . Since the morphology of these cells is
characteristic not only of neurons but of oligodendrocytes as
well (25), we conclude thatMAP lA is abundant in oligoden-
drocytes, consistent with our observations of sections of cen-
tral nervous system tissue (Fig. 6) .
Fig . 11 shows cells double-stained with antibody to glial
fibrillary acidic protein, a specific marker for astrocytes, and
anti-MAP IA . Most ofthe cells in the culture with flat, well-
spread morphology stained with anti-GFAP and were judged
on this basis to be astrocytes . Those cells also stained positively
with anti-MAP IA, but the intensity of fluorescence was
considerably lower than for oligodendrocytes (for a direct
comparison see Figs . 9 a and 10a) . Dividing astrocytes were
also observed occasionally, and the mitotic spindles in those
cells were brightly stained with anti-MAP IA . Staining ofthe
spindle was generally observed in dividing cells in these and
other cultures, as will be discussed in the accompanying paper
(4).
DISCUSSION
Previous work from this laboratory revealed that MAP 1 was
as abundant in microtubules purified from bovine white
matter as in microtubules purified from cerebral cortex (40) .
This led us to predict that, in contrast to MAP 2, MAP 1
FIGURE 10
￿
Localization of MAP 1A in cultured oligodendrocytes .
A coverslip containing primary new born rat brain cells was double
labeled with monoclonal anti-MAP 1A (a) and rabbit anti-myelin
basic protein (b) followed by rhodamine sheep anti-mouse IgG and
fluorescein goat anti-rabbit IgG . Anti-MAP 1A stained two cells in
this field very brightly, and produced light staining of numerous
other cells. The brightly staining cells also reacted with antimyelin
basic protein, identifying them as oligodendrocytes . Bar, 10 wm . x
650 .
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￿
Localization ofMAP 1A in cultured astrocytes . A cov-
erslip containing primary new born rat brain cells was double
labeled with monoclonal anti-MAP 1A (a and c) and rabbit anti-glial
fibrillary acidic protein (b and d), a marker for astrocytes . Second
antibodies were rhodamine sheep anti-mouse IgG and fluorescein
goatanti-rabbit IgG . The large cell shown in aand b is in interphase,
while the cell in cand d is undergoing mitosis . Bar, 10ym . x 650 .
would be found in axons, glial cells, or both . In the present
study, we examined the distribution of the major polypeptide
component ofMAP 1 by immunofluorescence microscopy of
tissue sections and primary cultures of brain cells using a
monoclonal antibody . We have found that MAP 1 consists
of at least three electrophoretic species, the principal one of
which, designated MAP IA, is recognized exclusively by our
antibody. We found thatMAP IA, like MAP 2, is prominent
in neurons . In contrast toMAP 2,MAP 1A was easily detected
in rat brain white matter, while both proteins were abundant
ingray matter, confirming theearlier biochemical results from
our laboratory . We have shown that MAP IA is present in
identifiable axons as well as in identifiable dendrites . In
addition, we have found that MAP IA, unlike MAP 2, is
prominent in oligodendrocytes and is detectable in astrocytes,
as well. Thus, our work stands in contradiction to that of
Matus et al. (23), who concluded on the basis of studies using
an antibody preparation directed against unfractionated high
molecular weight MAP, that these MAP were absent from
axons and glial cells .
Heterogeneity of Map 1
While MAP 1 has been treated as a single biochemical
entity, we noted several electrophoretic bands in the MAP I
region ofSDS gels. These bands were more striking in micro-
tubules prepared from white matter than from gray matter
(Bloom and Vafee, unpublished observations) . We do not
know whether this represents a real concentration difference
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in MAP 1B and MAP 1C in white matter vs . gray matter, a
result that is potentially of considerable interest, or whether
MAP 1B and MAP 1C are obscured by the heavy MAP 2
bands in gray matter preparations . Both MAP IA and MAP
1B ran as relatively broad electrophoretic bands . This was
observed both on 4% polyacrylamide gels prepared according
to Laemmli (21), as in Fig. 1, and on 3-5% polyacrylamide
gradient, SDS-urea gels (not shown) prepared according to
Pfister et al . (31) . The basis for this behavior is not understood,
though it may indicate that MAP 1A and MAP 1B are
themselves composed of numerous polypeptides differing
slightly in electrophoretic mobility .
The monoclonal antibody we described here reacted with
the entire MAP 1A band, indicating that ifMAP 1A were
complex, the components ofthis electrophoretic species must
be closely related . It is possible that MAP 1 B and MAP 1C
represent proteolytic fragments ofMAP IA lacking the anti-
genic site recognized by our antibody . This possibility can be
virtually eliminated for MAP IC because of the resistance of
this band to digestion by chymotrypsin (Fig. I C). IfMAP IC
were derived from the larger polypeptides, they should show
evidence ofa protease resistant region at least as large asMAP
1C . Instead, MAP 1A and MAP 1B were totally digested to
products oflower molecular weight than MAP 1C. The ques-
tion of whether MAP 1B is also a distinct protein or merely
a fragment ofMAP IA cannot be answered with certainty at
this time . However, in view of the reproducible ratio of the
two bands that we have observed in our preparations, and, as
noted above, evidence of a specific enrichment of MAP 1 B
in white matter, we are inclined to consider MAP IA and
MAP 1B distinct proteins . In the following paper (4) we
demonstrate by immunofluorescence microscopy that MAP
IA is localized on microtubules in cultured cells, and is
therefore a true MAP. At this time we do not know whether
MAP 1B and MAP 1C behave asMAP by immunocytochem-
ical criteria. We are currently raising antibodies to MAP I B
and MAP 1C to characterize these species further.
Distribution of MAP 1A in the Nervous System
Several points regarding the distribution of MAP IA de-
serve comment. Staining of processes clearly identifiable as
axons was observed throughout the brain and spinal cord .
However, the staining intensity ofaxons by anti-MAP 1A was
quite variable . In major cerebral white matter tracts (see Figs.
2-4) bright staining was observed, while white matter tracts
in the cerebellum and spinal cord (see Fig . 6) tended to be
less intensely stained. Climbing fiber and parallel fiber axons
of the cerebellar cortex were also weakly stained (see Fig. 7).
Thus, we cannot state as a general rule that all axons contain
high concentrations ofMAP IA . Perhaps the concentration
of MAP IA varies with axon type, or the antigenic site
recognized by our particular antibody is differentially blocked
by interaction with other proteins . Alternatively, there may
be real differences in the cytoskeletal composition of different
axons for reasons that are not yet clear.
The detectability of MAP 1A in axons distinguishes this
protein from MAP 2 in terms ofsubcellular distribution . The
discovery of MAP IA in two types of glial cells further
distinguishes this protein fromMAP 2 . Oligodendrocytes were
brightly stained in culture, and cells with the characteristics
of oligodendrocytes were prominently labeled in spinal cord
white matter (Fig. 6) and other white matter regions . Astro-
cytes were also positive for MAP 1A in primary brain cellcultures, though we were unable to detect MAP IA in these
cellsin vivo. Several factors may explain why astrocytes were
stained by anti-MAP IA in culture, but not in vivo. First,
immunofluorescence microscopy is more sensitive for cul-
tured cell monolayers than for the tissue sections, due in part
to differences in specimen thickness (no more than a few jm
for cultures vs. 20 um for tissue sections). Next, the staining
intensity with anti-MAP 1A was substantially greater for
dividing than nondividing astrocytes in culture. Since mature
brain and spinal cord contain few, if any, dividing astrocytes,
it is not surprising that no such cells were stained by anti-
MAP lA in tissue sections. Finally, immature astrocytes, such
as those present in the primary newborn rat brain cultures,
have been reported to be far richer in microtubules than more
mature astrocytes, such as those found in the 3-4-mo-old rats
from which we obtained brain sections (30). Collectively, these
considerations may explain why astrocytes were stained by
anti-MAP 1A in primary brain cell cultures, but not in tissue
sections.
The distributions of MAP lA and MAP 2 in the nervous
system are clearly distinct. However, similarities in their dis-
tributions are noteworthy. Throughout brain and spinal cord
gray matter, both MAP lA and MAP 2 are heavily concen-
trated in neuronal dendrites and cell bodies. Double immu-
nofluorescence with antibodies to the two MAP have enabled
us to demonstrate that individual cell bodies and dendrites
may contain high levels of both MAP IA and MAP 2.
Examples of this in the cerebral cortex and spinal cord are
shown in Fig. 8. Thus, while axons, oligodendrocytes and
astrocytes express detectable levels of MAP IA only, this
protein may be found in combination with high levels of
MAP 2 in neuronal perikarya and dendrites.
Functional Considerations
Two observations regarding the distribution of MAP IA
and MAP 2 are relevant to the question of how these MAP
function in cells. First, the distribution of the two proteins is
not identical. This conclusion was suggested by our earlier
biochemical results (40), but can now be made more emphat-
ically on the basis of immunofluorescence microscopy. With
regard to this point, we note that differences between MAP 1
and MAP 2, such as those observed in axons and in glial cells,
may be relative rather than absolute. This is suggested by our
earlier observation that MAP 2 was not entirely absent in
white matter, but was present at low levels (40), despite the
absence of significant immunoreactivity in white matter (8,
24; Fig. 3 b in this paper). Nevertheless, whether the absence
ofMAP 2 in cellscontaining MAP lA is absolute or relative,
it seems reasonable to conclude now that the two proteins
cannot function cooperatively in cells in a simple stoichio-
metric fashion. Though MAP 1 and MAP 2 are immunolog-
ically cross-reactive, respectively, to the erythrocyte mem-
braneproteins ankyrin and spectrin (2, 7), which interact with
one another in a defined stoichiometry, our studies indicate
that MAP 1 A and MAP 2 are likely to act independently in
the cell. The second observation relevant to the question of
MAP function is the coincident presence of MAP IA and
MAP 2 within individual neuronal perikarya and dendritic
processes (Fig. 8). Here, the two proteins may serve different
functions within the same cytoplasm.
Existing evidence from this laboratory indicates that MAP
2 is involved at least in mediating the interaction of micro-
tubules with intermediate filaments (3). In the accompanying
paper (4) we report that no evidence supporting such a func-
tion for MAP 1 A was obtained. Rather, this protein occurs in
the mitotic spindle of a wide variety of cells, as well as on
cytoplasmic microtubulesin nondividing cells. The functional
implications of these findings and further observations are
discussed in the next paper(4).
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